Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 Jun 23 EFFECT Notice of effectiveness
-
1 Jun 23 POS AM Prospectus update (post-effective amendment)
- 4 May 23 POS AM Prospectus update (post-effective amendment)
- 31 May 22 EFFECT Notice of effectiveness
- 26 May 22 POS AM Prospectus update (post-effective amendment)
- 2 Dec 21 EFFECT Notice of effectiveness
- 24 Nov 21 S-1/A IPO registration (amended)
- 4 Nov 21 S-1 IPO registration
RAPH similar filings
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use, in this Registration Statement No. 333-260766 on Form S-1, of our report dated March 30, 2022, relating to the financial statements of Raphael Pharmaceutical Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Brightman Almagor Zohar & Co.
Certified Public Accountants
A Firm in the Deloitte Global Network
Tel Aviv, Israel
June 1, 2023